Related Experiment Video
Updated: Jun 25, 2026
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Bladder cancer SNP panel predicts susceptibility and survival
Angeline S Andrew1, Jiang Gui, Arthur C Sanderson
1Section of Biostatistics and Epidemiology, Department of Community and Family Medicine, Dartmouth Medical School, Lebanon, NH 03756, USA. Angeline.Andrew@dartmouth.edu
Human Genetics
|March 3, 2009
Summary
Genetic variations in key genes impact bladder cancer risk and survival. Specific SNPs in MTHFD2, TEP1, IL8RB, CASP9, and EPHX1 influence susceptibility and patient outcomes, offering potential for clinical application.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Bladder cancer is a prevalent malignancy in Western countries, affecting both men and women.
- Genetic factors, particularly single nucleotide polymorphisms (SNPs) in genes involved in crucial cellular processes, are not fully understood in relation to bladder cancer.
- Investigating these genetic variations is essential for understanding disease mechanisms and improving patient outcomes.
Purpose of the Study:
- To assess the association between genetic variations in genes regulating telomere maintenance, mitosis, inflammation, and apoptosis and bladder cancer susceptibility.
- To evaluate the impact of these genetic variations on patient survival following a bladder cancer diagnosis.
Main Methods:
- A population-based study was conducted involving 832 bladder cancer cases and 1,191 controls.
- Genetic variations (SNPs) in genes such as MTHFD2, TEP1, IL8RB, CASP9, and EPHX1 were analyzed.
- Statistical analyses were performed to determine associations with cancer risk (Odds Ratios) and survival (Hazard Ratios).
Main Results:
- Increased bladder cancer risk was linked to variants in MTHFD2 (OR 1.7) and TEP1 (OR 1.8).
- A decreased risk was associated with the IL8RB gene variant (OR 0.6).
- Shorter survival was observed with apoptotic gene variants like CASP9 (HR 1.8), while EPHX1 variants correlated with longer survival (HR 0.4).
Conclusions:
- Specific SNPs in genes involved in methyl metabolism, telomere maintenance, inflammation, apoptosis, and detoxification are associated with bladder cancer risk and survival.
- These findings highlight potential genetic biomarkers for bladder cancer.
- Further validation in diverse populations is recommended for clinical utility of identified SNPs.
